Comprehensive real-world comparisons between baricitinib and dupilumab treatments for moderate severe atopic dermatitis

被引：0
|
作者：
Cho, Yung-Tsu [1 ,2 ]
Lee, Meng-Sui [3 ,4 ]
Chang, Wen -Yu [5 ,6 ]
Lu, Yea-Ting [1 ,2 ]
Chu, Chia -Yu [1 ,2 ]
Chan, Tom C. [1 ,2 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Dermatol, 7 Chung Shan South Rd, Taipei 100225, Taiwan
[2] Natl Taiwan Univ, Coll Med, 7 Chung Shan South Rd, Taipei 100225, Taiwan
[3] Taipei City Hosp, Dept Dermatol, Taipei, Taiwan
[4] Natl Yang Ming Chiao Tung Univ, Dept Dermatol, Taipei, Taiwan
[5] I Shou Univ, E Da Canc Hosp, Dept Dermatol, Kaohsiung, Taiwan
[6] I Shou Univ, Coll Med, Sch Med Int Students, Kaohsiung, Taiwan
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2024年 / 12卷 / 07期
关键词：
D O I：
10.1016/j.jaip.2024.04.008
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1924 / 1927.e1
页数：5
相关论文
共 50 条
  • [41] Comparison of Efficacy of Baricitinib and Dupilumab in the Treatment of Chinese Moderate-To-Severe Atopic Dermatitis: A Retrospective Study
    Liu, Bo
    Song, Xiaoting
    Liao, Shuanglu
    Luan, Tingting
    Zhao, Zuotao
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (10) : 966 - 974
  • [42] Real-world use of dupilumab for 53 patients with atopic dermatitis in Japan
    Matsutani, Masako
    Imai, Yasutomo
    Inoue, Yukako
    Hosotani, Yuka
    Kusakabe, Minori
    Natsuaki, Masaru
    Yamanishi, Kiyofumi
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2020, 3 (02) : 35 - 36
  • [43] Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study
    Torres, T.
    Paiva-Lopes, M. J.
    Goncalo, M.
    Claro, C.
    Oliveira, M.
    Gomes, J.
    Vieira, A. P.
    Amoedo, P.
    Alpalhao, M.
    Nogueira, M.
    Santiago, F.
    Henrique, M.
    Amaro, C.
    Esteves, T.
    Alves, J.
    Cerejeira, D.
    Mendes-Bastos, P.
    Pestana, M.
    Ramos, L.
    Rocha, J.
    Carvalho, R.
    Teixeira, L.
    Selores, M.
    Mota, A.
    Filipe, P.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2554 - 2559
  • [44] Upadacitinib for the treatment of moderate-to-severe atopic dermatitis in real-world clinical practice
    Tran, Vanessa
    Ross, Gayle
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 11 - 11
  • [45] Dupilumab for moderate-severe atopic dermatitis: a real-world, single-center retrospective study of 122 patients in the United States
    Emmerich, Veronica K.
    Williams, Josiah A.
    Hrin, Matthew L.
    Feldman, Steven R.
    Strowd, Lindsay C.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (04) : 524 - 525
  • [46] Dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kraft, Magdalena
    Worm, Margitta
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (04) : 301 - 310
  • [47] Effectiveness of abrocitinib for the treatment of moderate-to-severe atopic dermatitis in patients switched from dupilumab and/or tralokinumab: A real-world retrospective study
    Keow, Samantha
    Abu-Hilal, Mohannad
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (04) : 734 - 735
  • [48] Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China
    Wang, Yuyi
    Jia, Ruiling
    Hu, Qin
    Tao, Xiao
    He, Qi
    Luo, Guangying
    Xiong, Qiong
    Zhang, Zhongyu
    Xiao, Yujuan
    Liu, Yi
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [49] Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
    Berna-Rico, Emilio
    Fiz-Benito, Esther
    Busto-Leis, Jose Manuel
    Servera-Negre, Guillermo
    de Lucas-Laguna, Raul
    Feito-Rodriguez, Marta
    DERMATOLOGY, 2024, 240 (02) : 337 - 342
  • [50] Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis patients with chronic renal insufficiency: a real-world retrospective study in China
    Peng, Cong
    Cao, Qiaozhi
    Xiong, Feng
    Xu, Hui
    Li, Jie
    MEDCOMM, 2024, 5 (10):
12345